High TSTA3 Expression as a Candidate Biomarker for Poor Prognosis of Patients With ESCC-Reference-Cited by-同舟云学术

High TSTA3 Expression as a Candidate Biomarker for Poor Prognosis of Patients With ESCC

Published:2018-01 Issue: Volume:17 Page:153303381878140
ISSN:1533-0346
Container-title:Technology in Cancer Research & Treatment
language:en
Short-container-title:Technol Cancer Res Treat

Author:

Yang Jie¹²³,Kong Pengzhou¹²,Yang Jian¹²,Jia Zhiwu¹²,Hu Xiaoling¹²⁴,Wang Zianyi¹⁵,Cui Heyang¹²,Bi Yanghui¹²,Qian Yu¹²,Li Hongyi¹²,Wang Fang¹²,Yang Bin¹²⁶,Yan Ting¹²,Ma Yanchun¹²,Zhang Ling¹²,Cheng Caixia¹²⁷,Song Bin¹²⁸,Li Yaoping¹²⁹,Xu Enwei¹²¹⁰,Liu Haiyan¹²,Gao Wei¹²¹¹¹²,Wang Juan¹²,Liu Yiqian¹²,Zhai Yuanfang¹²¹³,Chang Lu¹²,Wang Yi¹²,Zhang Yingchun¹²¹³,Shi Ruyi¹²,Liu Jing¹²¹⁴,Wang Qi³,Cheng Xiaolong¹²¹³,Cui Yongping¹²

Affiliation:

1. Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China

2. Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China

3. Department of Gastroenterology, The Second Hospital, Shanxi Medical University, Taiyuan, Shanxi, PR China

4. Department of Pharmacology, Shanxi Medical University, Taiyuan, Shanxi, PR China

5. Taiyuan Lingde Secondary School, Taiyuan, Shanxi, PR China

6. Department of General Surgery, Shanxi Cancer Hospital, Taiyuan, Shanxi, PR China

7. Department of Pathology, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi, PR China

8. Department of Oncology, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi, PR China

9. Department of Anorectum, Shanxi Provincial People’s Hospital, Taiyuan, Shanxi, China

10. Department of Pathology, Shanxi Cancer Hospital, Taiyuan, Shanxi, PR China

11. Shanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, Taiyuan, Shanxi, PR China

12. Department of Otolaryngology Head & Neck Surgery, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi, PR China

13. Department of Anatomy, Shanxi Medical University, Taiyuan, Shanxi, PR China

14. Department of General Surgery, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi, PR China

Funder

Research Project Supported by Shanxi Scholarship Council of China

Publisher

SAGE Publications

Subject

Cancer Research,Oncology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1533033818781405

Reference41 articles.

1. Population Attributable Risks of Esophageal and Gastric Cancers

2. Cancer statistics in China, 2015

3. Genomic analyses reveal FAM84B and the NOTCH pathway are associated with the progression of esophageal squamous cell carcinoma

4. Expression of carbohydrate antigens in human pulmonary adenocarcinoma

5. Targeting Selectins and Their Ligands in Cancer

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TSTA3 overexpression promotes malignant characteristics in LUSC by regulating LAMP2-mediated autophagy and tumor microenvironment;Cancer Cell International;2023-11-20

2. Copy number variations in esophageal squamous cell carcinoma: Emerging cancer drivers and biomarkers (Review);Oncology Reports;2023-11-16

3. FUCA2 and TSTA3 expression in gastric cancer: candidate biomarkers of malignant transformation;Folia Histochemica et Cytobiologica;2022-12-30

4. Establishment of prognostic risk model and drug sensitivity based on prognostic related genes of esophageal cancer;Scientific Reports;2022-05-14

5. Eriodictyol suppresses the malignant progression of colorectal cancer by downregulating tissue specific transplantation antigen P35B (TSTA3) expression to restrain fucosylation;Bioengineered;2022-02-19